CBO Issues Cost Estimate for Ensuring Patient Access to Critical Breakthrough Products Act
November 23, 2024
November 23, 2024
WASHINGTON, Nov. 23 -- The Congressional Budget Office issued the following cost estimate on Nov. 18, 2024, for the Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 1691):
* * *
Bill Summary
H.R. 1691 would require Medicare to automatically cover devices approved under the Breakthrough Devices Program of the Food and Drug Administration (FDA). That program is directed at simplifying the approval process for devices used in the treatment o . . .
* * *
Bill Summary
H.R. 1691 would require Medicare to automatically cover devices approved under the Breakthrough Devices Program of the Food and Drug Administration (FDA). That program is directed at simplifying the approval process for devices used in the treatment o . . .